Coordinated care of the patient with vascular disease is difficult due to the diversity of the diseases that affect the circulatory system and the specialization of medicine. As a result, physicians will treat only that aspect of the disease that intersects with their area of expertise. To accelerate the development of an integrated faculty, to improve patient care and to encourage multidisciplinary research in vascular disease, the following proposals are made: 1) To formally organize existing clinical services into a unified Vascular Disease Resource Center (VDRC). 2) To develop a vascular medicine fellowship. 3) To develop a focused integrated educational program . 4) To promote multidisciplinary research in vascular disease. The strength of the programs proposed by the candidate are based upon the growing cooperation among formerly fragmented clinical and research groups within Northwestern University Medical School. The programs that the candidate propose will accelerate this process, leading to a stronger more vital program in vascular disease. The institution has made resources available to initiate the program and to begin a vascular medicine fellowship.
| Carr, S; Farb, A; Pearce, W H et al. (1996) Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 23:755-65;discussion 765-6 |
| Carr, S C; Pearce, W H; Vogelzang, R L et al. (1996) Current management of visceral artery aneurysms. Surgery 120:627-33;discussion 633-4 |
| Pearce, W H; Koch, A E (1996) Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci 800:175-85 |
| McMillan, W D; Patterson, B K; Keen, R R et al. (1995) In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol 15:1139-44 |
| Daly, J W; Padgett, W; Thompson, R D et al. (1986) Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flow. Biochem Pharmacol 35:2467-81 |
